Skip to main content

Advertisement

Table 2 Cox multivariate analysis of breast cancer specific and recurrence-free survivals

From: Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

   Breast cancer specific survival Recurrence-free survival
Cases Predictor Haz Rat 95% CI P Haz Rat 95% CI P
  SRAP 1.580 0.35-7.01 0.547 0.356 0.29-5.63 0.729
Whole cohort Age 2.576 1.50-4.40 < 0.001 1.507 1.39-3.60 < 0.0001
n = 372 ER 0.213 0.12-0.36 < 0.001 0.124 0.24-0.64 < 0.0001
  Node 3.214 1.8-5.61 < 0.001 1.84 1.67-4.39 < 0.0001
  SRAP 1.489 0.31-6.99 0.614 1.387 0.29-6.43 0.676
ER- Age 2.556 1.30-5.00 0.006 2.515 1.29-4.88 0.007
n = 101 Node 2.788 1.33-5.82 0.006 2.547 1.25-5.18 0.010
  SRAP × age 0.216 0.01-2.61 0.228 0.231 0.01-2.79 0.249
  SRAP × node 1.421 0.31-6.99 0.688 1.422 0.29-6.43 0.686
  SRAP 4.213 1.47-12.0 0.007 3.392 1.46-7.87 0.005
ER+ Age 1.637 0.75-3.54 0.210 1.656 0.88-3.09 0.113
n = 271 Node 3.466 1.45-8.26 0.005 2.721 1.40-5.27 0.003
  SRAP × age 0.316 0.09-1.05 0.060 0.337 0.12-0.89 0.030
  SRAP × node 0.474 1.47-12.0 0.216 0.539 1.46-7.87 0.210
  1. CI = confidence interval; ER = estrogen receptor; Haz Rat = hazard ratio; SRAP = steroid receptor RNA activator protein; + = positive; - = negative.
  2. P values correspond to cox regression model. Significant P values are bolded.